U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
102151102151Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary HyperparathyroidismRecruitingNo Results AvailablePrimary Hyperparathyroidism (PHPT)https://ClinicalTrials.gov/show/NCT01228786
102152102152The Efficacy of Health Navigation® for Cancer-Related Fatigue in Cancer SurvivorsEnrolling by invitationNo Results AvailableCancer-related FatigueBehavioral: Tailored web-based care program (Health Navigation®)https://ClinicalTrials.gov/show/NCT01228773
102153102153A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate CancerCompletedNo Results AvailableProstate NeoplasmsDrug: ASG-5MEhttps://ClinicalTrials.gov/show/NCT01228760
102154102154A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)CompletedHas ResultsEpilepsy|Generalized Tonic-Clonic SeizuresDrug: Levetiracetam|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01228747
102155102155A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) WActive, not recruitingNo Results AvailableMetastatic Colorectal CancerDrug: Cetuximab + Oxaliplatin + 5FU/FA|Drug: Oxaliplatin + 5FU/FAhttps://ClinicalTrials.gov/show/NCT01228734
102156102156Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using the Eye Tracker and Retest Function of Spectralis® SD-OCT in Glaucomatous Eyes and Healthy ControlsTerminatedNo Results AvailableGlaucomaDevice: Spectralis® SD-OCT, Heidelberg Engineering GmbH, Hhttps://ClinicalTrials.gov/show/NCT01228721
102157102157Effects of an Active Implementation of a Guideline for Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailableImplementation of a Chronic Disease Management Programme|COPDOther: Active implementation of a guideline for chronic diseasehttps://ClinicalTrials.gov/show/NCT01228708
102158102158Prospective Study of the Impact of Systemic Corticosteroid Use on Measures of Sleep Disordered BreathingCompletedNo Results AvailableSleep ApneaOther: sleep studyhttps://ClinicalTrials.gov/show/NCT01228695
102159102159Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeActive, not recruitingNo Results AvailableSIADH|Non-SIADH Hyponatremia|Non-HyponatremiaDrug: Tolvaptanhttps://ClinicalTrials.gov/show/NCT01228682
102160102160Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or BCompletedNo Results AvailableCongenital Bleeding Disorder|Haemophilia A|Haemophilia B|HealthyDrug: NNC 0172-0000-2021|Drug: NNC 0172-0000-2021|Drug: placebohttps://ClinicalTrials.gov/show/NCT01228669
102161102161Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone FuroateSuspendedNo Results AvailablePlaque PsoriasisDrug: mometasone furoate + salicylic acid|Drug: Mometasone furoatehttps://ClinicalTrials.gov/show/NCT01228656
102162102162Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two DrugsWithdrawnNo Results AvailableChronic Renal FailureBiological: Pancreatic enzimes|Device: Creon ®https://ClinicalTrials.gov/show/NCT01228643
102163102163Comparative Effectiveness of Two Associations of Loratadine + Pseudoephedrine, Cloratadd-d ® (Coated Pill) Produced by the Laboratory Ems and Claritin-d ® (dräger), Produced by Schering-plough in Patients With Perennial Allergic RhinitisCompletedNo Results AvailablePerennial Allergic RhinitisDrug: Loratadine + pseudoephedrinehttps://ClinicalTrials.gov/show/NCT01228630
102164102164Single-dose Pharmacokinetics of Oral Nicotine Replacement ProductsCompletedNo Results AvailableTobacco DependenceDrug: Nicotine|Drug: Nicotine Gumhttps://ClinicalTrials.gov/show/NCT01228617
102165102165Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In BrazilCompletedNo Results AvailableAttention-deficit/Hyperactivity DisorderDrug: methylphenidate (Ritalin®)https://ClinicalTrials.gov/show/NCT01228604
102166102166Pilot Dispensing Evaluation of a Plus Power LensCompletedHas ResultsHyperopiaDevice: Acuvue Advance Plus|Device: Acuvue Advancehttps://ClinicalTrials.gov/show/NCT01228591
102167102167Multi-vitamins, HAART and HIV/AIDS in UgandaCompletedNo Results AvailableHIV/AIDSDietary Supplement: Multivitamin supplements B,C and Ehttps://ClinicalTrials.gov/show/NCT01228578
102168102168Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®CompletedNo Results AvailableHead and Neck CarcinomaOther: Radiotherapy + Erbitux® + placebo|Other: Radiotherapy+Erbitux+OTD70DERMhttps://ClinicalTrials.gov/show/NCT01228565
102169102169The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute MigraineNot yet recruitingNo Results AvailableMigraine Disorders|Migraine Headache|Migraine|Acute MigraineDrug: Topical, intra-oral ketoprofen gel|Other: Placebo gelhttps://ClinicalTrials.gov/show/NCT01228552
102170102170Breaking the Cycle IV: Military PTSD (MPTSD) Treatment StudyCompletedNo Results AvailablePTSD|Anger|AggressionBehavioral: TARGET (Trauma Affect Regulation)|Behavioral: Prolonged Exposurehttps://ClinicalTrials.gov/show/NCT01228539
102171102171A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot UlcersCompletedNo Results AvailableFoot Ulcers, DiabeticDevice: PriMatrixhttps://ClinicalTrials.gov/show/NCT01228526
102172102172Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)CompletedNo Results AvailableAtopic DermatitisDrug: ZK245186|Drug: Placebo (vehicle without active ingredient)https://ClinicalTrials.gov/show/NCT01228513
102173102173The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded TrialWithdrawnNo Results AvailableFoot Ulcer, DiabeticDevice: PriMatrixhttps://ClinicalTrials.gov/show/NCT01228500
102174102174Influence of Oxidative Dysbalance on Secondary OsteoarthritisRecruitingNo Results AvailableOsteoarthritishttps://ClinicalTrials.gov/show/NCT01228487
102175102175Single Embryo Transfer vs. Double Embryo Transfer in an Oocyte Donation ProgrammeTerminatedNo Results AvailableInfertility|Oocyte Recipient|Single Embryo Transfer/Double Embryo Transfer|Cumulative Pregnancy Rate|Multiple PregnancyOther: Select the Number of embryos to transferhttps://ClinicalTrials.gov/show/NCT01228474
102176102176Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma PatientsRecruitingNo Results AvailableFatigue|Hodgkin Lymphomahttps://ClinicalTrials.gov/show/NCT01228461
102177102177In-Room PET in Proton Radiation TherapyRecruitingNo Results AvailableBrain Tumor|Head and Neck Tumor|Skull Base TumorProcedure: PET scanhttps://ClinicalTrials.gov/show/NCT01228448
102178102178IPI-504 in NSCLC Patients With ALK TranslocationsTerminatedHas ResultsLung Cancer|Stage IIIb Lung Cancer|Stage IV Lung CancerDrug: IPI-504https://ClinicalTrials.gov/show/NCT01228435
102179102179Pharmacokinetics and Pharmacodynamics of Interferon Alpha 2ACompletedNo Results AvailableHealthyBiological: Interferon alpha 2ahttps://ClinicalTrials.gov/show/NCT01228422
102180102180Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?RecruitingNo Results AvailablePsoriasisDrug: Acitretin 17.5 mg/dayhttps://ClinicalTrials.gov/show/NCT01228409

* Görseller ve İçerik tekif hakkına sahip olabilir